Abstract
This study aimed to characterise Bordetella pertussis isolates circulating in Poland since 1959. Sequence analysis of ptxA, ptxC, prn, tcfA, fim2, fim3 and ptxP for 175 clinical isolates and currently and previously used vaccine strains was performed. Clinical isolates from the period 1995–2013 were found to be different to three currently used vaccine strains harbouring the allelic combination ptxA2–ptxC1–ptxP1–prn1–tcfA2–fim2-1–fim3-1, seen frequently in Poland in the early pertussis vaccination period but not found after 1995. Generally, among B. pertussis isolates from the period 2000–2013, two genotypes predominated, ptxA1–ptxC1–ptxP1–prn1–tcfA2–fim2-2–fim3-1 and ptxA1–ptxC1–ptxP1–prn2–tcfA2–fim2-1–fim3-1, with frequencies of 45 % and 32.5 %, respectively. The isolates harbouring ptxA1–ptxC2–ptxP3–prn2–tcfA2–fim2-1–fim3-2 and ptxA1–ptxC2–ptxP3–prn2–tcfA2–fim2-1–fim3-1 profiles, currently highly prevalent within other European Union (EU) countries, were rarely found in Poland, as they circulated in the period 2000–2013 with frequencies of 10 % and 5 %, respectively. We hypothesise that several previous changes of strain composition in whole-cell pertussis vaccine produced locally and used since 1960 in Poland resulted in a more diverse immune pressure in the population, resulting in different prevalence of alleles compared to elsewhere.
Similar content being viewed by others
References
He Q, Mertsola J (2008) Factors contributing to pertussis resurgence. Future Microbiol 3:329–339. doi:10.2217/17460913.3.3.329
Cherry JD (2012) Epidemic pertussis in 2012—the resurgence of a vaccine-preventable disease. N Engl J Med 367(9):785–787. doi:10.1056/NEJMp1209051
Octavia S, Sintchenko V, Gilbert GL, Lawrence A, Keil AD, Hogg G et al (2012) Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008–2010. J Infect Dis 205(8):1220–1224. doi:10.1093/infdis/jis178
Somerville RL, Grant CC, Scragg RK, Thomas MG (2007) Hospitalisations due to pertussis in New Zealand in the pre-immunisation and mass immunisation eras. J Paediatr Child Health 43:147–153. doi:10.1111/j.1440-1754.2007.01034.x
European Centre for Disease Prevention and Control (ECDC) (2011) Annual epidemiological report 2011—reporting on 2009 surveillance data and 2010 epidemic intelligence data
Mooi FR, van Loo IHM, van Gent M, He Q, Bart MJ, Heuvelman KJ et al (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15:1206–1213. doi:10.3201/eid1508.081511
Mooi FR, Van Der Maas NAT, De Melker HE (2014) Pertussis resurgence: waning immunity and pathogen adaptation—two sides of the same coin. Epidemiol Infect 142:685–694. doi:10.1017/S0950268813000071
Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J (2004) Pertussis in Poland. Int J Epidemiol 33:358–365. doi:10.1093/ije/dyh012
Czarkowski MP, Cielebak E, Kondej E, Staszewska E; Department of Epidemiology, National Institute of Public Health—National Institute of Hygiene (NIPH-NIH) (2013) Infectious diseases and poisonings in Poland in 2012
Cherry JD (2013) Pertussis: challenges today and for the future. PLoS Pathog 9:e1003418. doi:10.1371/journal.ppat.1003418
Advani A, Van der Heide HGJ, Hallander HO, Mooi FR (2009) Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods 78:297–301. doi:10.1016/j.mimet.2009.06.019
Advani A, Hallander HO, Dalby T, Krogfelt KA, Guiso N, Njamkepo E et al (2013) Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol 51:422–428. doi:10.1128/JCM.02036-12
Hallander H, Advani A, Riffelmann M, von König CHW, Caro V, Guiso N et al (2007) Bordetella pertussis strains circulating in Europe in 1999 to 2004 as determined by pulsed-field gel electrophoresis. J Clin Microbiol 45:3257–3262. doi:10.1128/JCM.00864-07
van Loo IHM, Heuvelman KJ, King AJ, Mooi FR (2002) Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40:1994–2001
Schouls LM, van der Heide HGJ, Vauterin L, Vauterin P, Mooi FR (2004) Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol 186:5496–5505. doi:10.1128/JB.186.16.5496-5505.2004
Petersen RF, Dalby T, Dragsted DM, Mooi F, Lambertsen L (2012) Temporal trends in Bordetella pertussis populations, Denmark, 1949–2010. Emerg Infect Dis 18:767–774. doi:10.3201/eid1805.110812
van Gent M, Bart MJ, van der Heide HGJ, Heuvelman KJ, Kallonen T, He Q et al (2011) SNP-based typing: a useful tool to study Bordetella pertussis populations. PLoS One 6:e20340. doi:10.1371/journal.pone.0020340
Packard ER, Parton R, Coote JG, Fry NK (2004) Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK. J Med Microbiol 53:355–365
van Amersfoorth SCM, Schouls LM, van der Heide HGJ, Advani A, Hallander HO, Bondeson K et al (2005) Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 43:2837–2843. doi:10.1128/JCM.43.6.2837-2843.2005
Mooi FR, van Oirschot H, Heuvelman K, van der Heide HG, Gaastra W, Willems RJ (1998) Polymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 66:670–675
de Gouw D, Hermans PW, Bootsma HJ, Zomer A, Heuvelman K, Diavatopoulos DA et al (2014) Differentially expressed genes in Bordetella pertussis strains belonging to a lineage which recently spread globally. PLoS One 9:e84523. doi:10.1371/journal.pone.0084523
Fry NK, Neal S, Harrison TG, Miller E, Matthews R, George RC (2001) Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom. Infect Immun 69:5520–5528
Mosiej E, Augustynowicz E, Zawadka M, Dabrowski W, Lutyńska A (2011) Strain variation among Bordetella pertussis isolates circulating in Poland after 50 years of whole-cell pertussis vaccine use. J Clin Microbiol 49:1452–1457. doi:10.1128/JCM.01487-10
Advani A, Gustafsson L, Ahrén C, Mooi FR, Hallander HO (2011) Appearance of Fim3 and ptxP3-Bordetella pertussis strains, in two regions of Sweden with different vaccination programs. Vaccine 18(29):3438–3442. doi:10.1016/j.vaccine.2011.02.070
Hegerle N, Paris A-S, Brun D, Dore G, Njamkepo E, Guillot S et al (2012) Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 18:E340–E346. doi:10.1111/j.1469-0691.2012.03925.x
Kallonen T, Mertsola J, Mooi FR, He Q (2012) Rapid detection of the recently emerged Bordetella pertussis strains with the ptxP3 pertussis toxin promoter allele by real-time PCR. Clin Microbiol Infect 18:E377–E379. doi:10.1111/j.1469-0691.2012.04000.x
Schmidtke AJ, Boney KO, Martin SW, Skoff TH, Tondella ML, Tatti KM (2012) Population diversity among Bordetella pertussis isolates, United States, 1935–2009. Emerg Infect Dis 18:1248–1255. doi:10.3201/eid1808.120082
Lam C, Octavia S, Bahrame Z, Sintchenko V, Gilbert GL, Lan R (2012) Selection and emergence of pertussis toxin promoter ptxP3 allele in the evolution of Bordetella pertussis. Infect Genet Evol 12:492–495. doi:10.1016/j.meegid.2012.01.001
Shuel M, Jamieson FB, Tang P, Brown S, Farrell D, Martin I et al (2013) Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone. Int J Infect Dis 17:e413–e417. doi:10.1016/j.ijid.2012.12.015
Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H, Shibayama K, Kamachi K (2013) Genetic analysis of Bordetella pertussis isolates from the 2008–2010 pertussis epidemic in Japan. PLoS One 8:e77165. doi:10.1371/journal.pone.0077165
Gzyl A, Augustynowicz E, Gniadek G, Rabczenko D, Dulny G, Slusarczyk J (2004) Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates. Vaccine 22(17–18):2122–2128. doi:10.1016/j.vaccine.2003.12.006
Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J (2004) Potency of pertussis component in the DTP vaccine—an overview of three decade study in Poland. Biologicals 32:129–137
Zawadka M, Mosiej E, Polak M, Krysztopa-Grzybowska K, Moskała B, Rokosz-Chudziak N et al (2014) Consistency of Bordetella pertussis vaccine seed strains and potency of whole-cell pertussis vaccine still in use in Poland. Biologicals 42:123–127. doi:10.1016/j.biologicals.2013.11.006
Acknowledgements
We thank Marjolein van Gent and Frits Mooi (RVIM, The Netherlands) for their help in the assignment of novel ptxA and ptxC alleles.
Funding
The sequencing of ptxA, ptxC, prn, tcfA, fim2, fim3 and ptxP were supported by the Ministry of Education and Science in Poland (grant number N N404 206 539) and the National Science Centre (grant number 2011/01/N/NZ7/05305).
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(XLSX 21.0 KB)
Rights and permissions
About this article
Cite this article
Mosiej, E., Zawadka, M., Krysztopa-Grzybowska, K. et al. Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959–2013. Eur J Clin Microbiol Infect Dis 34, 147–152 (2015). https://doi.org/10.1007/s10096-014-2216-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-014-2216-6